Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial
by Cortés, Jorge Eduardo (Author)
, Khaled, Samer (Author)
, Martinelli, Giovanni (Author)
, Perl, Alexander E (Author)
, Ganguly, Siddhartha (Author)
, Russell, Nigel (Author)
, Krämer, Alwin (Author)
, Dombret, Hervé (Author)
, Hogge, Donna (Author)
, Jonas, Brian A (Author)
, Leung, Anskar Yu-Hung (Author)
, Mehta, Priyanka (Author)
, Montesinos, Pau (Author)
, Radsak, Markus (Author)
, Sica, Simona (Author)
, Arunachalam, Meena (Author)
, Holmes, Melissa (Author)
, Kobayashi, Ken (Author)
, Namuyinga, Ruth (Author)
, Ge, Nanxiang (Author)
, Yver, Antoine (Author)
, Zhang, Yufen (Author)
, Levis, Mark J (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource